在药物研发的发现阶段,识别出具有前景良好的 ADME 和药代动力学特性的候选药物,能够为未来的临床试验和监管批准奠定基础。然而,将长期研究成功转化为成功的结果需要临床规模下可靠且合格的测量方法。
Q2 Solutions 的全球生物分析服务网络在靶向多结构域蛋白、抗体、寡核苷酸、抗体偶联药和肽的生物标志物测定和基于细胞的生物分析测定方面拥有丰富专业知识。
具体优势包括:
If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...
Q2 Solutions is a leading drug discovery and development laboratory services organization with over 30 years of experience specializing in GLP-compliant bioanalytical testing. Our updated and...
The analysis and distribution of pharmaceuticals in tissue is increasingly important in understanding the full action of drugs in vivo. Across molecular types from very small molecules to larger...